Sonic Healthcare Limited (SKHHY)
OTHER OTC:SKHHY
Want to see SKHHY full AI Analyst Report?
SKHHY Stock Chart & Stats
$14.96
-$0.18(-1.00%)
At close: 4:00 PM EST
$14.96
-$0.18(-1.00%)
Day’s Range― - ―
52-Week Range$13.06 - $18.71
Previous CloseN/A
Volume5.11K
Average Volume (3M)19.70K
Market Cap
$6.96B
Enterprise Value$17.14B
Total Cash (Recent Filing)$556.57M
Total Debt (Recent Filing)$7.34B
Price to Earnings (P/E)18.4
Beta0.42
Next Earnings
Aug 20, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield4.08%
Share Statistics
EPS (TTM)0.81
Shares Outstanding494,237,950
10 Day Avg. Volume29,893
30 Day Avg. Volume19,698
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.57
Price to Sales (P/S)1.35
P/FCF Ratio13.57
Enterprise Value/Market Cap2.46
Enterprise Value/Revenue2.20
Enterprise Value/Gross Profit7.73
Enterprise Value/Ebitda12.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.87
Revenue Forecast (FY)$7.80B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationVery strong free cash flow (FCF grew ~72.7% with FCF/NI ~0.74) provides durable financial flexibility. It funds capex, dividends and M&A integration, supports investment‑grade targets and potential buybacks or debt reduction, and cushions working‑capital shocks over multiple quarters.
Consistent Revenue Growth With Stable Gross MarginsSonic's steady revenue growth (~6.5%) coupled with a stable gross margin (~33%) signals resilient demand for core pathology and imaging services and disciplined cost control. That durability supports predictable EBITDA conversion and underpins recurring cash generation over the medium term.
Diversified Global Platform And Integration ProgressA broad geographic footprint with active integration (Germany LADR, UK contract wins, radiology growth and advanced diagnostics/digital pathology) reduces dependence on any single market. Successful integration and hub builds can drive synergies, scale benefits, and longer‑term margin expansion.
Bears Say
U.S. Margin Pressure And RestructuringU.S. operations are a structural weakness: low underlying organic growth, margin decline and ongoing restructuring (including rationalisation of anatomical pathology practices). These issues can persist and require time and investment to restore margins, dragging consolidated profitability.
Billing Disruption Raised Net Debt And Working CapitalThe Change Healthcare billing disruption materially inflated receivables and short‑term liabilities, increasing net debt and working‑capital needs. That weakens near‑term cash conversion, raises funding costs and constrains capital management until collections normalize, limiting strategic flexibility.
Regulatory Reimbursement Uncertainty In GermanyProposed private fee schedule reform (GOA) in Germany introduces reimbursement uncertainty in a key growth market. Unknown timing and financial impact could impair margins and returns from recent German investments, complicating forecastable cashflows until policy outcomes are clarified.
Sonic Healthcare News
SKHHY FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest stock price was $13.06 and its highest was $18.71 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is $6.96B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 53 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported $0.353 earnings per share for the quarter, missing the consensus estimate of $0.357 by -$0.004.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Overvalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of $0.316 which represents an annual dividend yield of 4.08%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.48.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of $0.353 in its last earnings report, missing expectations of $0.357. Following the earnings report the stock price went up 9.657%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in SKHHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.48%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
19.27%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.
SKHHY Company Deck
SKHHY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call presents a largely positive operational and financial picture: strong H1 results (revenue, EBITDA, net profit), maintained full-year EBITDA guidance, margin improvement at group level (+30 bps), successful integration progress in major acquisitions (Germany LADR and Swiss deals), and continued organic growth across several markets (Australia, Germany, UK, Radiology). Offsetting these positives are concentrated challenges in the U.S. (margin pressure, restructuring and delayed revenue collection benefits), elevated short-term net debt and working capital due to acquisitions and the Change Healthcare billing disruption, FX headwinds for H2, and some regulatory/wage uncertainties (Germany GOA reform and Australian Fair Work outcomes). Management has clear remediation and capital management plans (operating review, sale-and-leaseback program, potential buybacks) and has retained guidance, supporting a constructive outlook despite identifiable near-term risks.View all SKHHY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---